Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine as Adjuvant to Bupivacaine in TAP Block for Postoperative Analgesia After Caesarean Delivery
NCT05785377Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Dec 2027
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of neostigmine in postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoint: Time of the first postoperative analgesic requirement at 24 hours. Planned start Dec 2027; status: not yet recruiting.
02
Drugs
neostigmine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05785377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05785377.